Top Markets
Coin of the day
Intech Biopharm Corporation Intech Biopharm Corporation

Intech Biopharm Corporation

6461
Rankning i aktier #22451
Intech Biopharm Corporation is a pharmaceutical company dedicated to the global... Intech Biopharm Corporation is a pharmaceutical company dedicated to the global development and production of generic medications for respiratory conditions. Their portfolio includes innovative drug delivery systems, such as iLEF (inhaled low ethanol formulation), a proprietary metered dose inhaler platform specifically engineered for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Additionally, they offer a dry powder inhaler (DPI) technology, which utilizes blisters and capsules for precise dosage. These therapeutic solutions are marketed under various brand names, including SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011. Established in Taipei, Taiwan, in 2010, the company maintains its headquarters in the city.
Aktiekurs
$0.49606484
Senast synkroniserad: 2026-08-21
Marknadsvärde
$88.47M
Förändring (1 dag)
-1.58%
Förändring (1 år)
-22.51%
Land
TW
Handel Intech Biopharm Corporation (6461)

Kategori

Historik för aktiesplit för Intech Biopharm Corporation (6461)
Aktien Intech Biopharm Corporation (symbol: 6461) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 23, 2026.
En 6461-aktie köpt före Aug 23, 2026 motsvarar nu 0 6461-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH